Atori 携帯型ネブライザー by Xiyu Zheng is a highly esteemed winner of the very prestigious 2022 A' Design Award 鉄賞 in 医療機器・医療設備デザイン Competition Category.

鉄医療製品· 2022

Atori 携帯型ネブライザー

by Xiyu Zheng

Client: TAO Design Studio

A' Design Award 鉄賞 Winner in 医療製品 Category

21,930

Verified Award Winner

Verify Award Status for #137277

View at A' Design Award Press Release Award Badge

Colors

The Design

About Atori 携帯型ネブライザー

Atoriは、アレルギー性鼻炎の症状緩和のために設計された携帯型ネブライザーです。小型の超音波ユニットが液状の薬剤を微細なミストに変え、吸入を可能にします。角度のついたノズルと湾曲したシリコーン製ノーズパッドが鼻柱に沿って当たるため、特別な練習をしなくてもノズルが正しい位置で鼻孔に入ります。スイッチにより一回に放出される薬量をコントロールできます。シェルは射出成形によって製造され、薬剤ボトルは交換可能で製品寿命を延ばします。コンパクトなサイズにより、公共の場でも人目を気にせず使用できます。

The Recognition

About the A' Design Award 鉄賞

Atori 携帯型ネブライザーは、よく設計された創造物に期待される専門的・産業的要件を満たす優れたデザインに授与される、権威ある評価である A' Design Award 鉄賞の受賞作品です。鉄賞の受賞作品は、制作者の高い技量、高度な専門性、専門家としての理解、創造的な能力を示しています。Atori 携帯型ネブライザーは、高く評価され、称賛され、愛される、実用的で革新的な創造物であることが期待されます。この A' Design Award 鉄賞を受賞したデザインは、業界のベストプラクティスを統合し、ノウハウと才能に結びついた有能な技術的特性を備えています。Atori 携帯型ネブライザーは、その徹底ぶりで尊敬され、世界をより良い場所にするための生活の質の向上をもたらすよう設計されています。

Behind the Design

Press Kit

Credits, team members and technical details provided by the designer.

Unique Properties: Atori's unconscious design, based on user behaviour, nebulizes the medication so that they can use it elegantly and discreetly. In response to the large number of patients who misuse nasal spray products, this product allows patients to administer the medication correctly without learning by modifying the angle of the nozzle and adding a structural curve against the nasal cartilage, and controlling the dosage released at one time by the switch.
Dimensions & Packaging: 85mm x 65mm x 30mm
Tags: Rhinitis，Nebulizer，Healthcare, Portable, Sustainable
Production Technology: The design uses a small ultrasonic nebulizer to convert liquid medication into a mist for inhalation therapy. Injection molding process to produce an integrated shell, with a replacement bottle of medicine to use, to extend the product life.
Material: Silicone, PET, PVC.
Design Challenge: During the design process, our team was looking for a portable and elegant way to deliver rhinitis medication and conquer the socially awkward situations that patients may encounter during the design process. With considerations around unconscious movements, ergonomic improvement, hygiene, and safety, we finally realized this design through the migration of nebulization technology to meet the needs of patients and enhance the experience of using the product.
Research: The current rhinitis drugs on the market lack consideration in using scenarios, user experience, user psychology, and ergonomics. The inhalation nebulizer products are mainly used for oral inhalation therapy, and the nebulization technology has the potential to be used for treating rhinitis effectively. Our project team worked closely with professional physicians to solve those issues above and delivered an innovative and user-centered product design solution.
Inspiration: Allergic rhinitis is a prevalent disease nowadays, but patients lack suitable emergency methods when they have a sudden outbreak of the disease in public. The methods they usually use, such as blowing the nose with tissues, cannot remove the allergen in time, and the traditional spray-in medications are not suitable for use in public places due to the way of using and the product size. Hence, patients often embarrass themselves for their runny noses.
Project Duration: The project started in January 2022 in Shanghai and finished in January 2022 in Shanghai, and was exhibited in H’art Beijing in January 2022.
Operation Flow: The patient opens the lid of the portable nebulizer for rhinitis, holds it according to its shape and places the silicone nose pad against the nasal column, at which point the nozzle is naturally inserted into the nostril. Next, the user presses the switch to start the nebulized medication spray while inhaling it and then the symptoms are relieved.
Team Members: An Chen
Wentao Zhang
Xiyu Zheng
Xueying Sun
Jie Zhang
Image Credits: Image #5: photographer An Chen, Atori, 2022.